A pioneering AI technology designed to speed up patient care through improved assessment in the emergency department is currently being trialled at the Royal London Hospital (RLH) as part of a groundbreaking collaboration between Bingli, Barts Health and Barts Life Sciences (BLS). Emergency Departments (ED) are under significant pressure, with the four-hour wait time target consistently missed. BLS is at...
Clinical trials are important for helping to improve health outcomes for our community. A Clinical Research Facility (CRF) is both a physical place and importantly a team of skilled healthcare professionals who help to deliver research studies. Barts Health is a highly research-active organisation, and last year recruited more people into clinical trials than ever before. Next year, we will...
The healthcare research landscape has advanced dramatically in the past decade. Breakthroughs in areas such as genomics now enable us to diagnose and treat diseases with unprecedented precision. In this blog post, we spoke with Professor Sir Mark Caulfield, Vice Principal for Health Queen Mary University of London, Faculty of Medicine and Dentistry and Director of the NIHR Barts Biomedical...
UK Science Parks and Innovation Districts have long been pivotal engines of economic growth, driving technological innovation, economic development, and enhancing global competitiveness. In this blog, Dr. Grant Bourhill, MD at Barts Life Sciences and Board Director of the UK Science Park Association, explores the evolution of these clusters over the past few decades and the anticipated benefits of the...
A project using Artificial Intelligence to tackle cardiovascular healthcare inequalities in North East London has been awarded over £300,000 by Barts Charity. The PREDICT project will use patient data to predict and prevent emergency admissions to hospital for patients with heart valve disease. The 3-year project will translate medical notes into structured data which is suitable for identifying groups...
In a new collaboration with Barts Health’s Clinical Haematology team and Sanofi, Barts Life Sciences (BLS) aims to speed up diagnosis – and in turn treatment – of rare diseases. Rare diseases aren’t as rare as you might think. In fact, 1 in 17 people in Europe will be diagnosed with one. But despite being more common than originally imagined,...
Imagine a patient, whether just starting on a diagnostic pathway or already diagnosed with a chronic condition, missing a crucial procedure or follow-up appointment – the consequences can be significant, potentially leading to a delayed diagnosis or compromised care. Barts Life Sciences, in collaboration with Barts Health’s Business Intelligence Unit, has launched the TREAT project employing Natural Language Processing (NLP)...
Free support is being offered by Barts Life Sciences for small to medium-sized enterprises (SMEs) and innovators that are active or registered in London. The support brings in expertise on topics including developing NHS business cases, procurement, intellectual property, and health economics, with the aim of supporting scaling innovation alongside the NHS. Tailored guidance will also be offered to...
Barts Life Sciences is delighted to be supporting the Future Cities Forum’s “Knowledge Cities 2023” event on 23rd November, from 0930 – noon. Building on the pioneering life sciences work already undertaken at Barts Health NHS Trust and Queen Mary University of London, plans are underway for a major development of several plots adjacent to the Royal London Hospital, aiming...
Barts Life Sciences Futures Hubs were recently featured in Academic Health Science Network UCL Partners’ report on how NHS Trusts are using innovative ways to address social determinants of health. Four NHS trusts in North East London have shared approaches to tackling health inequalities addressing factors such as employment, increasing income, improving education, and reducing air pollution. Read the report...
Accessibility options
Translate the page